top of page

What Does It Mean for the Industry & Policy Makers?

We know our collaboration could help both you, as industry specialists, and traumatic brain injury (TBI) patients in making leaps and bounds in TBI treatment and recovery.

Right Patients. Right Data. Right Trials.


TBI symptoms can vary widely from person to person.

It is important to collect data from a large and diverse population to identify patterns and trends. With our patient-centric platform gathering symptom and trigger data around the world, you could gain access to a wealth of critical information that can then help shape better understanding, treatment, and policy surrounding TBI.

As we collect this data, we are building a data warehouse of unique, never before seen patient reported outcome data, developing models that can be applied in patient care [micro] and research applications [macro] levels.  This data can be used to design targeted clinical trials, assist policy makers to fund services specifically where the patients are reporting the deficits [i.e. the symptoms] and the pharmaceutical, device, industries can then recruit from our warehouse appropriate patients for a clinical trial.

Our Solution: Sallie™ The Virtual Therapy Dog

Sallie white backgrn BLINK.gif

Sallie™: An Innovative Patient Health Platform

Sallie™, the virtual therapy dog, not only allows patients to interact with their data, but we are building a data warehouse that allows researchers to examine visualizations and various “what if” scenarios before designing a clinical trial.

Sallie™ can FETCH data and target patients for the research industry. This is of benefit because it will assist in designing a clinical trial with better analytics and insights with a ready-matched group of patients available for a clinical trial. This unique process saves millions of dollars for clinical trial sponsors by reducing the timeline of the clinical trial through better patient retention and higher patient engagement. Another improvement is the ability to thwart Adverse Events (AEs) before they become Serious Adverse Events (SAEs).

Device Images-02.png

Some of Our Stakeholders Are:

Health & Human Service Departments

Pharmaceutical Companies

Medical Device Companies

Contract Research Organizations (CROs)

Why Should You Collaborate with Power of Patients®?

Overall, collaboration with our portal can be a valuable and rewarding experience for stakeholders in the TBI industry. By working together, we can develop more effective treatments and interventions that improve patient outcomes and quality of life, while also advancing the field of TBI research and development.

Access to Valuable Data

Our unique and innovative portal provides access to a wealth of data that can be used to inform research and development in the TBI industry. By collaborating with us, you can gain access to this data and use it to develop new treatments, interventions, and products that are tailored to the needs of TBI patients.

Improved Patient Outcomes

By working with our portal, you can help to improve the outcomes of TBI patients. The data we collect can be used to identify trends and patterns in TBI, allowing for the development of more targeted and effective treatments that improve patient outcomes and quality of life.

Better Understanding

TBI is a complex condition that affects different people in different ways. By collaborating with our portal, you can gain a better understanding of the condition, including its causes, symptoms, and triggers. This knowledge can be used to develop more effective interventions and treatments that address the unique needs of individual patients.

Competitive Advantage

In a crowded and competitive market, collaborating with our portal can give you a competitive advantage. By using the data we collect to inform your research and development, you can develop products and services that are more effective and tailored to the needs of TBI patients, setting you apart from your competitors.

All-Inclusive CNS Portal

We started with TBI, but we listened to the patients using Sallie™. People suffering from Stroke, Alzheimer’s, Parkinson’s, Lewy Body, MCI, Autism, and all neurological conditions were trying to train Sallie™ for their own use. So, we decided to expand Sallie’s™ abilities and offer a simple and robust platform to collect this data too. Our goal for these indications is to expand our proprietary algorithms, digitally phenotype these patients before their conditions become too severe. Earlier detection means earlier treatment with the hope of slowing the progression of these neurological conditions.

Get Started:
Collaborate With Us Today

To get started with collaboration, simply reach out to our team and we'll be happy to discuss how we can work together to achieve our shared goals. We look forward to hearing from you and working together to improve the lives of TBI patients and their caregivers.

Here are 3 Easy Ways to Get Started NOW:

  • Ask for a FREE assessment of your recruitment strategy

  • Ask for a FREE data summary report

  • Ask for a demo

bottom of page